Court Properly Dismissed Most Securities Claims Against Drug Maker, Panel Rules
BOSTON — A First Circuit U.S. Court of Appeals panel on Nov. 28 substantially affirmed a federal district court’s dismissal of claims in a securities class action lawsuit against a pharmaceutical...To view the full article, register now.
Already a subscriber? Click here to view full article